Updates from The Motley Fool

Latest updates on RXI PHARMACEUTICALS from Fool.com.

There is no available coverage of RXI PHARMACEUTICALS at this time.

Stock Performance

RXII vs. S&P 500 | 2 Year Performance
RXII 1-Day Stock Chart
RXII 5-Day Stock Chart
RXII 1-Month Stock Chart
RXII 3-Month Stock Chart
RXII 6-Month Stock Chart
RXII 1-Year Stock Chart
RXII 2-Year Stock Chart
RXII 5-Year Stock Chart
View Interactive RXII Charts
Sponsored by

Key Data Points

Primary metrics and data points about RXI PHARMACEUTICALS.
Current Price: $2.25
Prev Close: $2.17
Open: $2.16
Bid: $2.24
Ask: $2.29
Day's Range: $2.16 - $2.25
52wk Range: $1.26 - $6.49
Volume: 8,279
Avg Vol 76,571
Market Cap: $147.04M
P/E (ttm): -0.31
EPS (ttm): -$6.92
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about RXI PHARMACEUTICALS.
CAPS Rating 2 out of 5
192 Outperform
21 Underperform
CAPS All Stars
19 Outperform
9 Underperform

How do you think RXI PHARMACEUTICALS will perform against the market?

You pick for RXI PHARMACEUTICALS is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Noah D. Beerman, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for RXI PHARMACEUTICALS.


  • Exchange: NASDAQ